Not Medicare Enrolled
Dr. William Sternheim, MD
Hematology & Oncology · Lake Worth, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sternheim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sternheim? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sternheim
Dr. William Sternheim is a hematology & oncology in Lake Worth, FL, with 19 years in practice. Based on federal Medicare data, Dr. Sternheim performed 76,339 Medicare services across 2,593 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sternheim received a total of $15,305 from 85 pharmaceutical and/or device companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sternheim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 10% volume in FL$ $15,305 industry payments
Medicare Practice Summary
Medicare Utilization ↗76,339
Medicare services
Top 10% in FL for hematology & oncology
2,593
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,018 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 59,250 | $1 | $4 |
| Denosumab injection (Prolia/Xgeva) | 6,180 | $19 | $32 |
| Epoetin alfa injection (Procrit) for anemia | 3,210 | $6 | $20 |
| Complete blood count (CBC) with differential | 1,219 | $8 | $24 |
| Blood draw (venipuncture) | 1,151 | $8 | $12 |
| Comprehensive metabolic blood panel | 742 | $10 | $38 |
| Lactate dehydrogenase (enzyme) level | 677 | $6 | $15 |
| Uric acid level test | 670 | $4 | $10 |
| Office visit, established patient (30-39 min) | 594 | $98 | $150 |
| Drug injection, under skin or into muscle | 284 | $11 | $45 |
| Ferritin level test (iron stores) | 251 | $13 | $47 |
| Iron level test | 251 | $6 | $30 |
| Transferrin (iron binding protein) level | 251 | $12 | $40 |
| Infusion, normal saline solution, 250 cc | 242 | $1 | $9 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 224 | $18 | $32 |
| Office visit, established patient (20-29 min) | 148 | $68 | $125 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 139 | $57 | $125 |
| Vitamin B-12 level test | 135 | $15 | $55 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 112 | $50 | $155 |
| Carcinoembryonic antigen (cea) protein level | 108 | $19 | $65 |
| Red blood count, manual test | 98 | $4 | $18 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 79 | $23 | $175 |
| Folic acid level test | 64 | $14 | $32 |
| Office visit, established patient, complex (40-54 min) | 57 | $139 | $200 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 47 | $20 | $55 |
| Administration of chemotherapy into vein, 1 hour or less | 46 | $102 | $270 |
| Drawing of blood for a medical problem | 33 | $70 | $150 |
| New patient office visit (45-59 min) | 25 | $133 | $215 |
| Thyroid stimulating hormone (TSH) test | 14 | $16 | $32 |
| Thyroxine (thyroid chemical), total | 13 | $7 | $13 |
| Thyroid hormone evaluation | 13 | $6 | $12 |
| New patient office visit, complex (60-74 min) | 12 | $166 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
78.2% high complexity
12.9% medium
8.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,305
Total received (2018-2024)
Avg $2,186/year across 7 years
Top 30% in FL for hematology & oncology
85
Companies
786
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,989 (91.4%)
Other
Charitable contributions, space rental, and other categories
$712 (4.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$603 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,107
2023$2,582
2022$2,197
2021$2,258
2020$1,753
2019$2,675
2018$2,733
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,724
Janssen Biotech, Inc.
$1,211
PFIZER INC.
$922
E.R. Squibb & Sons, L.L.C.
$661
AstraZeneca Pharmaceuticals LP
$652
Celgene Corporation
$641
Genentech USA, Inc.
$526
Amgen Inc.
$506
Takeda Pharmaceuticals U.S.A., Inc.
$502
Incyte Corporation
$471
Lilly USA, LLC
$456
GENZYME CORPORATION
$424
Seagen Inc.
$395
Merck Sharp & Dohme LLC
$340
Astellas Pharma US Inc
$323
Dova Pharmaceuticals
$320
Merck Sharp & Dohme Corporation
$319
GlaxoSmithKline, LLC.
$279
Exelixis Inc.
$259
Boehringer Ingelheim Pharmaceuticals, Inc.
$242
Eisai Inc.
$195
Daiichi Sankyo Inc.
$182
JAZZ PHARMACEUTICALS INC.
$181
Pharmacyclics LLC, An AbbVie Company
$174
NOVARTIS PHARMACEUTICALS CORPORATION
$167
TerSera Therapeutics LLC
$162
EISAI INC.
$141
AbbVie Inc.
$140
Kite Pharma, Inc.
$127
AbbVie, Inc.
$124
EMD Serono, Inc.
$124
ABBVIE INC.
$122
ARRAY BIOPHARMA INC
$117
Seattle Genetics, Inc.
$103
Regeneron Healthcare Solutions, Inc.
$88
Ipsen Biopharmaceuticals, Inc
$86
Clovis Oncology, Inc.
$79
Janssen Products, LP
$77
Pharmacosmos Therapeutics Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$68
SOBI, INC
$66
Bayer Healthcare Pharmaceuticals Inc.
$64
Deciphera Pharmaceuticals Inc.
$62
Puma Biotechnology, Inc.
$61
Sirtex Medical Inc
$60
AVEO Pharmaceuticals, Inc.
$58
Sobi, Inc
$56
PharmaEssentia USA Corporation
$54
Helsinn Therapeutics (U.S.), Inc.
$54
TAIHO ONCOLOGY, INC.
$52
Octapharma USA, Inc.
$52
Gilead Sciences, Inc.
$50
Verastem, Inc.
$49
Pharmacyclics LLC, an AbbVie Company
$42
BeiGene USA, Inc.
$39
MEDIVATION FIELD SOLUTIONS LLC
$39
Kyowa Kirin, Inc.
$39
Teva Pharmaceuticals USA, Inc.
$36
Acceleron Pharma, Inc.
$36
Foundation Medicine, Inc.
$36
PUMA BIOTECHNOLOGY, INC.
$36
Otsuka America Pharmaceutical, Inc.
$35
Intuitive Surgical, Inc.
$33
TESARO, Inc.
$32
Jazz Pharmaceuticals Inc.
$32
Janssen Pharmaceuticals, Inc
$32
Rigel Pharmaceuticals, Inc.
$30
Aurobindo Pharma USA, Inc.
$28
Myriad Genetic Laboratories, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Sun Pharmaceutical Industries Inc.
$24
Alexion Pharmaceuticals, Inc.
$23
MorphoSys, US Inc.
$22
Azurity Pharmaceuticals, Inc.
$21
Agios Pharmaceuticals, Inc.
$20
TG Therapeutics, Inc.
$20
Adaptive Biotechnologies Corporation
$19
Global Blood Therapeutics, Inc.
$19
TOLMAR Pharmaceuticals, Inc.
$19
Ethicon Inc.
$18
Blue Earth Diagnostics Limited
$18
Organon LLC
$18
Mylan Institutional Inc.
$16
Karyopharm Therapeutics Inc.
$15
Lexicon Pharmaceuticals, Inc.
$15
Top 3 companies account for 25.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Avastin · Axumin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · ENHERTU · EPKINLY · ERLEADA · EVENITY · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PYRUKYND · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tibsovo · UKONIQ · ULTOMIRIS · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · Vectibix · Venclexta · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $20 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
40
Per 100K population
2.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sternheim is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sternheim experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Sternheim performed 59,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sternheim receive payments from pharmaceutical companies?
Yes. Dr. Sternheim received a total of $15,305 from 85 companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sternheim's costs compare to other hematology & oncologys in Lake Worth?
Dr. Sternheim's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sternheim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Lake Worth
Browse hematology & oncologys in Lake Worth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology